These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7754773)
41. Anti-D treatment for chronic immune thrombocytopenic purpura: clinical and laboratory aspects. Sagripanti A; Ferretti A; Giannessi D; Carpi A; Bernini W; Ambrogi F; De Caterina R Biomed Pharmacother; 1998; 52(7-8):293-7. PubMed ID: 9809171 [TBL] [Abstract][Full Text] [Related]
42. Serum thrombopoietin levels in relation to disease status in patients with immune thrombocytopenic purpura. Kappers-Klunne MC; de Haan M; Struijk PC; van Vliet HH Br J Haematol; 2001 Dec; 115(4):1004-6. PubMed ID: 11843841 [TBL] [Abstract][Full Text] [Related]
43. Recombinant interferon alfa-2b therapy in children with immune thrombocytopenic purpura. Hayani A; Mahoney DH; Steuber CP; Saleem A Pediatr Hematol Oncol; 1993; 10(3):293-6. PubMed ID: 8217549 [No Abstract] [Full Text] [Related]
44. Successful treatment of idiopathic thrombocytopenic purpura-like syndrome in a cancer patient with low-dose interferon: case report and review of the literature. Tsoussis S; Ekonomidou F; Vourliotaki E; Karalis I; Dermitzakis A Am J Hematol; 2004 Aug; 76(4):353-9. PubMed ID: 15282668 [TBL] [Abstract][Full Text] [Related]
45. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children. Kjaersgaard M; Edslev PW; Hasle H Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275 [TBL] [Abstract][Full Text] [Related]
47. The use of interferon-alpha 2B in the treatment of chronic viral hepatitis in patients with preexisting idiopathic thrombocytopenic purpura. Yoshida EM; Rock NR; Zeng L; Haniak WA; Anderson FH Am J Gastroenterol; 1995 May; 90(5):854-5. PubMed ID: 7605454 [No Abstract] [Full Text] [Related]
48. Treatment options for chronic refractory idiopathic thrombocytopenic purpura in adults: focus on romiplostim and eltrombopag. Chouhan JD; Herrington JD Pharmacotherapy; 2010 Jul; 30(7):666-83. PubMed ID: 20575632 [TBL] [Abstract][Full Text] [Related]
53. Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura. Pacetti P; Garau D; Caramatti C; Mangoni L; Zamboni V; Canova N; Rizzoli V Curr Med Res Opin; 1997; 13(9):517-27. PubMed ID: 9169254 [TBL] [Abstract][Full Text] [Related]
54. [Idiopathic thrombocytopenic purpura in children]. Gebauer E; Vijatov G Med Pregl; 1998; 51(3-4):127-34. PubMed ID: 9611955 [TBL] [Abstract][Full Text] [Related]
55. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C; Reu FJ; Ho AD; Hensel M Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529 [TBL] [Abstract][Full Text] [Related]